Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Maria Salud Garcia-Gutiérrez"'
Autor:
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, Abraham B. Torregrosa, Gabriel Rubio, Marta Marín-Mayor, Gabriela B. Acosta, Maria Salud Garcia-Gutiérrez, Jorge Manzanares
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 9, p 4764 (2022)
The therapeutic benefits of the current medications for patients with psychiatric disorders contrast with a great variety of adverse effects. The endocannabinoid system (ECS) components have gained high interest as potential new targets for treating
Externí odkaz:
https://doaj.org/article/1094cab714df482ebd08ec69742c285a
Autor:
Adrián Viudez-Martínez, Abraham B. Torregrosa, Francisco Navarrete, María Salud García-Gutiérrez
Publikováno v:
Biomolecules, Vol 14, Iss 2, p 163 (2024)
Migraine is a highly prevalent neurological disorder. Among the risk factors identified, psychiatric comorbidities, such as depression, seem to play an important role in its onset and clinical course. Patients with migraine are 2.5 times more likely
Externí odkaz:
https://doaj.org/article/bac350a43d1f4ac9a30abe4d8bf67c40
Autor:
Daniela Navarro, Marta Marín-Mayor, Ani Gasparyan, María Salud García-Gutiérrez, Gabriel Rubio, Jorge Manzanares
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 23, p 16726 (2023)
Suicide is a serious global public health problem, with a worrying recent increase in suicide rates in both adolescent and adult populations. However, it is essential to recognize that suicide is preventable. A myriad of factors contributes to an ind
Externí odkaz:
https://doaj.org/article/8c363fdf06984b82a6b29ffa5596820b
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: This study aims to further characterize cannabidiol’s pharmacological and molecular profile as an antidepressant.Methods: Effects of cannabidiol (CBD), alone or combined with sertraline (STR), were evaluated in male CD1 mice (n = 48)
Externí odkaz:
https://doaj.org/article/02593ef4551740fe8d4e207a46656738
Autor:
Ani Gasparyan, Daniel Maldonado Sanchez, Francisco Navarrete, Ana Sion, Daniela Navarro, María Salud García-Gutiérrez, Gabriel Rubio Valladolid, Rosa Jurado Barba, Jorge Manzanares
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 1796 (2023)
The cognitive decline in people with substance use disorders is well known and can be found during both the dependence and drug abstinence phases. At the clinical level, cognitive decline impairs the response to addiction treatment and increases drop
Externí odkaz:
https://doaj.org/article/6dfb9b1440e342f0972d73d466eb8dcf
Autor:
Alvaro Morcuende, María Salud García-Gutiérrez, Simone Tambaro, Elena Nieto, Jorge Manzanares, Teresa Femenia
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Emotional behavior, memory, and learning have been associated with alterations in the immune system in neuropsychiatric and neurodegenerative diseases. In recent years, several studies pointed out the involvement of the cannabinoid receptor 2 (CB2r)
Externí odkaz:
https://doaj.org/article/bf274198561c41f58613cbd158d35743
Autor:
Francisco Navarrete, María Salud García-Gutiérrez, Ani Gasparyan, Amaya Austrich-Olivares, Jorge Manzanares
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Drug treatments available for the management of substance use disorders (SUD) present multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These facts hamper the clinical outcome and the quality of life of the pati
Externí odkaz:
https://doaj.org/article/642284f6721b4598b02915e4ed0b8535
Autor:
María Salud García-Gutiérrez, Francisco Navarrete, Ani Gasparyan, Daniela Navarro, Álvaro Morcuende, Teresa Femenía, Jorge Manzanares
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 11, p 5908 (2022)
Cumulative evidence has pointed out cannabinoid CB2 receptors (CB2r) as a potential therapeutic key target for treating alcohol use disorder (AUD). This review provides the most relevant results obtained from rodent and human studies, including an in
Externí odkaz:
https://doaj.org/article/08683221858c4ceea72895dc837e272f
Autor:
Francisco Navarrete, María Salud García-Gutiérrez, Ani Gasparyan, Amaya Austrich-Olivares, Teresa Femenía, Jorge Manzanares
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Nowadays, cannabis is the most consumed illicit drug. The global prevalence of the use of cannabis in 2017 was estimated in 188 million of people, 3.8% of worldwide population. Importantly, the legalization of cannabis in different countries, togethe
Externí odkaz:
https://doaj.org/article/7a5ec1a1e152452188de5dfc387e6fc4
Autor:
Amaya Austrich-Olivares, María Salud García-Gutiérrez, Lucía Illescas, Ani Gasparyan, Jorge Manzanares
Publikováno v:
Pharmaceuticals, Vol 15, Iss 4, p 473 (2022)
The anxiolytic and antidepressant properties of cannabidiol (CBD) have been evaluated in several studies. However, the molecular mechanisms involved in these actions remain unclear. A total of 130 male mice were used. CBD’s ability to modulate emot
Externí odkaz:
https://doaj.org/article/76a3620d81424896bb79abdc1524f21c